Yogaraja Guggulu: Traditional Uses, Evidence & Safety

TL;DR

Yogaraja Guggulu ("the king of formulations") is a classical joint tablet: guggul resin with 27 herbs, chitrak, trikatu, triphala, rasna, gokshura, devadaru, for arthritis, gout, sciatica, Vata joint disorders. Best evidence: an open-label study of 120 knee-arthritis patients. The formulation (with two oils) improved WOMAC scores over 12 weeks, unblinded, uncontrolled, confounded. Animal data agrees.

What it is

Yogaraja Guggulu is a guggulu preparation. It comes in tablet form. The formula: 27 herbs at 10 g each: Chitraka (Plumbago zeylanica), Pippalimoola (Piper longum root), Yavani (Trachyspermum ammi), Karavi (Piper chaba), Ajamoda, Jeeraka (cumin), Suradaru (Cedrus deodara), Chavya (Piper cubeba), Ela (cardamom), Saindhava lavana (rock salt), Kushta (Saussurea lappa), Rasna (Pluchea lanceolata), Gokshura (Tribulus terrestris), Dhanyaka (coriander), Triphala, Musta (Cyperus rotundus), Trikatu (ginger, black pepper, long pepper), Twak (cinnamon), Usheera (Vetiveria zizanioides), Yavakshara (barley alkali), Taleesapatra (Abies webbiana), Patra (Cinnamomum leaf), plus Vidanga in some versions. These are combined with 270 g of purified guggulu resin (Commiphora mukul) and ghee, rolled into 500 mg pills (Eayur; JETIR 2024).

The design logic: guggul resin as the anti-inflammatory, joint-targeting base. Pungent digestive herbs (trikatu, chitrak, ajwain) clear ama (metabolic residue). Rasna and gokshura are the Vata-pacifying joint herbs. Triphala is the mild detoxifier.

Traditional use

The batch data records Yogaraja Guggulu as pungent-bitter, heating (Ushna virya). Its prabhava: Vatahara (Vata-pacifying) and Shothahara (swelling-reducing). Classical indications: Amavata (rheumatoid arthritis), Adhyavata (gout), sciatica, chronic musculoskeletal pain, osteoarthritis, splenomegaly, abdominal tumors (gulma), bloating, piles, and worm infestation. It is said to increase digestion, complexion, strength, and immunity (Eayur; Gita Ayurvedic).

Tradition's testimony above. The laboratory's below. I keep the courtrooms separate.

What modern research says

Knee osteoarthritis study (human, n=120)

An open-label, multicenter, prospective study enrolled 120 patients aged 35–65 with primary knee osteoarthritis (ACR criteria, radiological changes). They received Yogaraj guggulu 500 mg thrice daily with lukewarm water after food. They also got Gandharvahasta taila 6 mL orally at bedtime and Dhanwantara taila applied externally twice daily, for 12 weeks. Total WOMAC scores and clinical symptoms reduced significantly from baseline to end of treatment (J Res Ayurvedic Sci 2019).

The measured take: 120 patients with validated outcome measures is the strongest human data in this batch. But it was open-label with no control group, and two co-therapies were given. The improvement cannot be attributed to Yogaraja Guggulu alone. Placebo/expectation effects are uncontrolled.

Comparative and preclinical work

A 2024 comparative study tested Agnikarma (thermal cautery) versus Yograja Guggulu in knee osteoarthritis (Janu Sandhigatavata). Both arms were assessed on pain, tenderness, swelling, range of movement, and crepitus (JETIR 2024). In rats, Yogaraja gulgulu showed anti-arthritic activity against Freund's adjuvant-induced paw swelling (J Phytol 2011).

What the evidence does not support (yet)

No blinded, placebo-controlled trial of Yogaraja Guggulu exists. Rheumatoid arthritis, gout, sciatica, and systemic indications are traditional only.

Safety & contraindications

Thyroid effects. In rats, a guggul extract increased thyroid activity (Tripathi et al. 1988, rat study), animal evidence, not a demonstrated human interaction. People with thyroid disorders or on thyroid medication should still use it only under supervision.

Bleeding and surgery. Purified guggul steroids inhibited platelet aggregation in laboratory (in-vitro) work, cell-level evidence, not human studies (Sahni et al., in-vitro). Out of caution, stop before surgery and use carefully with anticoagulants or antiplatelet drugs. The clinical bleeding risk is unquantified.

Skin and GI effects. Guggulu preparations can cause rash, nausea, or loose stools in some people.

Pregnancy. No safety data were identified. Traditional texts use it broadly, but that is not evidence of safety. Avoid without supervision.

Joint red flags. Hot swollen single joint, fever with joint pain, inability to bear weight, or numbness/weakness down the leg (possible cauda equina) need urgent medical evaluation. Not a guggulu tablet.

FAQs

What is Yogaraja Guggulu?

A classical Ayurvedic joint tablet of purified guggul resin with 27 herbs (chitrak, pippalimoola, trikatu, triphala, rasna, gokshura, devadaru, and others). It is traditionally used for arthritis, gout, and sciatica (Eayur).

Does it work for knee osteoarthritis?

A 120-patient open-label study found significant WOMAC improvement over 12 weeks. But with no control group and two co-therapies, the result is suggestive, not conclusive (J Res Ayurvedic Sci 2019).

How is it taken?

Labels direct 1–2 tablets twice or thrice daily with lukewarm water after food, or as a physician directs (Gita Ayurvedic). The OA study used 500 mg thrice daily after food for 12 weeks.

Is it safe with thyroid medication?

Animal evidence suggests guggul can stimulate thyroid activity. No human interaction study exists. Discuss with your doctor. This is a real concern to check, not an established interaction.

Why is there no formal dosage section in this article?

Our editorial rule is to state doses only with a pharmacopoeial monograph or clinical-trial citation. Label directions are reported above as labeling. The OA study's 500 mg thrice-daily regimen is reported as study detail. Neither is a standing recommendation. So we omit a dosage section.

Sources

The composition (27 herbs at 10 g each; purified guggulu 270 g; ghee; 500 mg pills) and traditional indications (Amavata/rheumatoid arthritis, Adhyavata/gout, krumi, dushta vrana, pleeha, gulma, anaha) are Eayur (page) and the JETIR 2024 comparative study (PDF). The knee-OA study (n=120, 500 mg TID + oils, 12 weeks, WOMAC reduced significantly) is the Journal of Research in Ayurvedic Sciences 2019 (abstract). The rat adjuvant-arthritis study is J Phytol 2011 (PDF).

Disclaimer

This article is for educational purposes only and is not medical advice. Yogaraja Guggulu has no blinded, placebo-controlled trial evidence; the best human data is an uncontrolled open-label study with co-therapies. Animal and laboratory evidence suggests possible effects on thyroid function and platelet aggregation, but neither is established in humans — discuss with a doctor if you take thyroid, anticoagulant, or antiplatelet medication, or are pregnant. Joint red flags (hot swollen joint, fever, inability to bear weight, leg numbness/weakness) need urgent medical care. Talk to a qualified healthcare practitioner before use.